Oncolytic Adenovirus Market

Future Market Insights

Key Insight

The oncolytic adenovirus market is projected to grow from USD 140.2 billion in 2025 to USD 288.9 billion by 2035, at a CAGR of 7.5%. Adenoviruses-based Oncolytic Viruses will dominate with a 47.3% market share, while melanoma will lead the application segment with a 29.8% share.

August 21, 2025

Anurag Sharma

287 Pages

Cite this Report

Oncolytic Adenovirus Market

https://www.futuremarketinsights.com/reports/oncolytic-adenovirus-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

CG Oncology Inc
Replimune Group Inc
Thus

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncolytic Adenovirus Market

Key Players

Similar Industry Reports